Reports have demonstrated that glioma patients with wild-type IDH have a worse prognosis than those with IDH mutation [20], and our results confirmed that KIF4A overexpression in patients with wild-type IDH was greater than that in patients with IDH mutation. The gene discussed is KIF4A; the disease is glioma.